180 related articles for article (PubMed ID: 27695417)
1. Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles.
Giacomazzi A; Degan M; Calabria S; Meneguzzi A; Minuz P
Front Pharmacol; 2016; 7():314. PubMed ID: 27695417
[TBL] [Abstract][Full Text] [Related]
2. Collagen-induced generation of platelet-derived microparticles in whole blood is dependent on ADP released from red blood cells and calcium ions.
Takano K; Asazuma N; Satoh K; Yatomi Y; Ozaki Y
Platelets; 2004 Jun; 15(4):223-9. PubMed ID: 15203713
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric detection of circulating platelet-derived microparticles in healthy adult horses.
Springer NL; Smith E; Brooks MB; Stokol T
Am J Vet Res; 2014 Oct; 75(10):879-85. PubMed ID: 25255176
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.
Mörtberg J; Lundwall K; Mobarrez F; Wallén H; Jacobson SH; Spaak J
BMC Nephrol; 2019 Mar; 20(1):71. PubMed ID: 30823870
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when stimulated by different physiological agonists.
Milioli M; Ibáñez-Vea M; Sidoli S; Palmisano G; Careri M; Larsen MR
J Proteomics; 2015 May; 121():56-66. PubMed ID: 25835965
[TBL] [Abstract][Full Text] [Related]
6. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M
FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
8. Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategy.
Tocchetti EV; Flower RL; Lloyd JV
Thromb Res; 2001 Jul; 103(1):47-55. PubMed ID: 11434945
[TBL] [Abstract][Full Text] [Related]
9.
Nijiati M; Saidaming A; Guoqing L
Ann Clin Lab Sci; 2017 Mar; 47(2):156-161. PubMed ID: 28442516
[TBL] [Abstract][Full Text] [Related]
10. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
Suades R; Padró T; Vilahur G; Badimon L
Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk.
Papadavid E; Diamanti K; Spathis A; Varoudi M; Andreadou I; Gravanis K; Theodoropoulos K; Karakitsos P; Lekakis J; Rigopoulos D; Ikonomidis I
World J Cardiol; 2016 Nov; 8(11):667-675. PubMed ID: 27957253
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric detection and procoagulant activity of circulating canine platelet-derived microparticles.
Helmond SE; Catalfamo JL; Brooks MB
Am J Vet Res; 2013 Feb; 74(2):207-15. PubMed ID: 23363344
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2.
Scavone M; Femia EA; Caroppo V; Cattaneo M
Eur Heart J; 2016 Nov; 37(44):3347-3356. PubMed ID: 26516174
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro.
Lin HC; Chang HW; Hsiao SH; Chou ML; Seghatchian J; Burnouf T
Transfus Apher Sci; 2015 Oct; 53(2):246-52. PubMed ID: 26597313
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the aggregation responses of camel platelets.
Al Ghumlas AK; Gader AG
Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
[TBL] [Abstract][Full Text] [Related]
16. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
18. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
19. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
20. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
